Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Tetracycline-induced hemolytic anemia

J J Mazza, M D Kryda

Journal of the American Academy of Dermatology

|June 1, 1980

Summary

Tetracyclines can cause hemolytic anemia, a rare blood disorder. This report details the first nonimmune-mediated case linked to tetracycline hydrochloride, highlighting the infrequent nature of this adverse effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Recurrent venous thromboembolism in patients with and without anticoagulation after inferior vena caval filter placement.

International angiology : a journal of the International Union of Angiology·2006

Same author

Risk assessment model for venothromboembolism in post-hospitalized patients.

International angiology : a journal of the International Union of Angiology·2005

Same author

Regulation of colony-stimulating factor-induced human myelopoiesis by transforming growth factor-beta isoforms.

Cytokines, cellular & molecular therapy·2002

Same author

Rectus sheath hematoma as a cause of acute abdominal pain.

American family physician·2002

Same author

Activity involvement among suicidal and nonsuicidal high-risk and typical adolescents.

Suicide & life-threatening behavior·2001

Same author

Approach to diagnosing lower extremity edema.

Comprehensive therapy·2001

Area of Science:

Hematology
Pharmacology
Internal Medicine

Background:

Tetracyclines are broad-spectrum antibiotics with established therapeutic uses.
Adverse hematologic effects, including hemolytic anemia, are known but rare complications of tetracycline therapy.

Observation:

This paper documents the third reported case of acquired hemolytic anemia associated with tetracycline use.
It specifically details the first instance of nonimmune-mediated hemolysis attributed to tetracycline hydrochloride.

Findings:

The presented case is the first documented nonimmune-mediated hemolytic anemia caused by tetracycline hydrochloride.
Literature review confirms the rarity of such hematologic side effects with tetracyclines.

Implications:

Clinicians should be aware of the potential for rare hematologic adverse events, such as nonimmune-mediated hemolytic anemia, with tetracycline hydrochloride.
This case adds to the understanding of tetracycline-induced hematotoxicity, emphasizing its infrequent occurrence.

Related Experiment Videos